• ARMSTRONG, R.A., JONES, R.L., MACDERMOT, J. & WILSON, N.H. (1986). Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics. Br. J. Pharmacol., 87, 543551.
  • CLAPP, L.H., TURCATO, S., HALL, S.J. & BALOCH, M. (1998). Evidence that Ca2+-activated K+ channels play a major role in mediating the vascular effects of iloprost and cicaprost. Eur. J. Pharmacol., 356, 215224.
  • COLEMAN, R.A., SMITH, W.L. & NARUMIYA, S. (1994). International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205229.
  • FROLICH, J.C. (1990). Prostacyclin in hypertension. J. Hyperten., 8, S73S78.
  • GRANT, S.M., & GOA, K.L. (1992). Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs, 43, 889924.
  • HASLAM, R.J., DAVIDSON, M.M. & DESJARDINS, J.V. (1978). Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the undirectional control of platelet function by cyclic AMP. Biochem. J., 176, 8395.
  • HOLZMANN, S., KUKOVETZ, W.R. & SCHMIDT, K. (1980). Mode of action of coronary arterial relaxation by prostacyclin. J. Cyclic. Nucleoltide. Res., 6, 451460.
  • JACKSON, W.F., KONIG, A., DAMBACHER, T. & BUSSE, R. (1993). Prostascyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am. J. Physiol., 264, H238H243.
  • OZAKI, H., ABE, A., UEHIGASHI, Y., KINOSHITA, M., HORI, M., MITSUISALTO, M. & KARAKI, H. (1996). Effects of a prostaglandin I2 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta. Jpn. J. Pharmacol., 71, 231237.
  • RIVA, C.M., MORGANROTH, M.L., LJUNGMAN, A.G., SCHOENEICH, S.O., MARKS, R.M., TODD, R.F., WARD, P.A. & BOXER, L.A. (1990). Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am. J. Respir. Cell. Molec. Biol., 3, 301309.
  • SCHRODER, G., BECKMANN, R. & SCHILLINGER, E. (1987). Studies on the vasorelaxant effects of and mechanisms of iloprost in isolated preparations. In Prostacyclin and its stable analogue iloprost. ed. Gryglewski, R.J. & Stock, G. pp. 129137. Berlin: Springer-Verlag.
  • SCHUBERT, R., SEREBRYAKOV, V.N., MEWES, H. & HOPP, H.H. (1997). Iloprost dilates rat small arteries: Role of KATP- and KCa- channel activation by cAMP-dependent protein kinase. Am. J. Physiol., 272, H1147H1156.
  • TURCATO, S. & CLAPP, L.H. (1998). Evidence that vasorelaxation induced by Gs coupled receptors is largely independent of cAMP in guinea-pig aorta. J. Mol. Cell. Cardiol., 30, A190.
  • VEGESNA, R.V. & DIAMOND, J. (1986). Elevation of cyclic AMP by prostacyclin is accompanied by relaxation of bovine coronary arteries and contraction of rabbit aortic rings. Eur. J. Pharmacol., 128, 2531.
  • WISE, H. & JONES, R.L. (1996). Focus on prostacyclin and its novel mimetics. Trends. Pharmacol. Sci., 17, 1721.